“If these cancer drugs could be introduced to the UK at these lower prices, they would be affordable and patients could benefit from them. For example dasatinib, used to treat leukaemia, is being sold in Brazil at less than half the UK price, and the cost price of production is 99% lower than the UK price. The pharmaceutical companies who developed these drugs are making vast profits every year, and so could afford to sell their drugs more cheaply."
As a blindness charity is accused of helping pharmacy giant block cheap drug that could help thousands we ask... should health charities stop taking cash from drug firms? Why is the RNIB campaigning against a drug that prevents sight loss? The RNIB receive funding from the drug company's more expensive rival The row has thrown a spotlight on the truth about charities and drug firms Health charities risk their reputations by accepting money from companys.
The vaccine, known as VSV-EBOV, even had had its results published in a respected journal, and health officials called them exciting. However, it then languished on a lab shelf after being licensed to a drug firm - until now.